Insmed Total Liabilities decreased by 10.1% to $1.37B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 19.5%, from $1.70B to $1.37B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows an upward trend with a 24.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $698.73M | $806.93M | $833.04M | $1.03B | $1.01B | $1.02B | $1.57B | $1.56B | $1.59B | $1.61B | $1.66B | $1.62B | $1.77B | $1.57B | $1.74B | $1.70B | $1.23B | $1.42B | $1.53B | $1.37B |
| QoQ Change | — | +15.5% | +3.2% | +24.1% | -2.4% | +1.6% | +53.1% | -0.4% | +2.1% | +1.2% | +2.9% | -2.3% | +9.1% | -11.4% | +10.8% | -2.1% | -27.8% | +15.0% | +7.8% | -10.1% |
| YoY Change | — | — | — | — | +44.4% | +27.0% | +88.3% | +51.2% | +58.0% | +57.5% | +5.9% | +3.9% | +11.1% | -2.8% | +4.7% | +4.9% | -30.6% | -9.8% | -12.3% | -19.5% |